标准剂量阿奇霉素在计划外剖宫产的 III 类肥胖患者中的应用。

Standard-Dose Azithromycin in Class III Obese Patients Undergoing Unscheduled Cesarean Delivery.

机构信息

Division of Maternal and Fetal Medicine, Obstetrics and Gynecology Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.

Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.

出版信息

Am J Perinatol. 2024 May;41(S 01):e2645-e2650. doi: 10.1055/a-2135-7084. Epub 2023 Jul 24.

Abstract

OBJECTIVE

Perioperative antibiotic prophylaxis reduces cesarean wound complications. This study investigates whether integration of standard-dose (500 mg) azithromycin prophylaxis reduced wound complications in patients with class III obesity (body mass index [BMI] ≥ 40 kg/m) undergoing unscheduled cesarean delivery.

STUDY DESIGN

Retrospective cohort study of patients with class III obesity undergoing unscheduled cesarean delivery in single hospital system from January 1, 2017, to January 1, 2020. A standard dose (500 mg) of azithromycin was integrated into system order sets in 2018. Medical history and postoperative wound outcomes were compared in pre- and postintegration cohorts. Wound complication was defined as composite of wound seroma, hematoma, superficial or deep infection.

RESULTS

A total of 1,273 patients met inclusion criteria, 303 patients in the preorder set group, and 970 patients in the postorder set group. Demographics were similar between the pre- and postintegration cohorts, including BMI (median: 44.4 kg/m,  = 0.84) and weight at delivery (mean: 121.2 ± 17.8 kg,  = 0.57). Patients in the postintegration cohort had lower rates of composite postpartum wound complication (7.9 vs. 13.9%,  = 0.002), superficial infection or deep infection/abscess (6.7 vs. 10.2%,  = 0.042), and postpartum readmission or unscheduled visits (18.7 vs. 24.4%,  < 0.029). Rates of chorioamnionitis and endometritis were similar between the pre- and postintegration groups (8.6 vs. 6.9%,  = 0.33, and 1.7 vs. 1.9%,  = 0.81, respectively). Patients in the postintegration cohort had lower risk of postoperative composite wound complication (unadjusted odds ratio [OR]: 0.54, confidence interval [CI]: 0.36-0.80,  = 0.002) and lower rates of wound infection (unadjusted OR: 0.63, 95% CI: 0.40-0.99,  = 0.044). When comparing patients who received azithromycin at delivery and patients who did not, standard-dose azithromycin reduced risk of postoperative wound complication (unadjusted OR: 0.67, 95% CI: 0.46-0.99,  = 0.043).

CONCLUSION

A standard dose of azithromycin provides adequate perioperative prophylaxis in class III obese patients, decreasing rates of postcesarean wound complications and unscheduled postpartum outpatient visits.

KEY POINTS

· Class III obese patients undergoing unscheduled cesarean have high rates of wound complications.. · Standard-dose azithromycin reduces risk of postcesarean wound infection in class III obese patients.. · Standard-dose azithromycin reduces readmission, unscheduled visits in class III obese patients..

摘要

目的

围手术期预防性使用抗生素可降低剖宫产伤口并发症。本研究旨在调查标准剂量(500mg)阿奇霉素预防用药是否可降低 3 级肥胖(体重指数 [BMI]≥40kg/m)患者行择期剖宫产时的伤口并发症。

研究设计

对 2017 年 1 月 1 日至 2020 年 1 月 1 日在单一医院系统中接受择期剖宫产的 3 级肥胖患者进行回顾性队列研究。2018 年,标准剂量(500mg)阿奇霉素被整合到系统医嘱中。比较了围手术期前、后队列的病史和术后伤口结局。将伤口血清肿、血肿、浅表或深部感染的复合症状定义为伤口并发症。

结果

共有 1273 名患者符合纳入标准,其中 303 名患者在围手术期前组,970 名患者在围手术期后组。两组患者的人口统计学特征相似,包括 BMI(中位数:44.4kg/m, = 0.84)和分娩时体重(均值:121.2 ± 17.8kg, = 0.57)。围手术期后组患者的复合产后伤口并发症发生率较低(7.9% vs. 13.9%, = 0.002)、浅表感染或深部感染/脓肿(6.7% vs. 10.2%, = 0.042)和产后再入院或非计划门诊就诊率(18.7% vs. 24.4%, < 0.029)较低。围手术期前、后组的绒毛膜羊膜炎和子宫内膜炎发生率相似(8.6% vs. 6.9%, = 0.33 和 1.7% vs. 1.9%, = 0.81)。围手术期后组患者的术后复合伤口并发症风险较低(未调整优势比 [OR]:0.54,95%置信区间 [CI]:0.36-0.80, = 0.002)和伤口感染发生率较低(未调整 OR:0.63,95%CI:0.40-0.99, = 0.044)。与分娩时未使用阿奇霉素的患者相比,使用标准剂量阿奇霉素的患者术后伤口并发症风险较低(未调整 OR:0.67,95%CI:0.46-0.99, = 0.043)。

结论

标准剂量阿奇霉素可为 3 级肥胖患者提供充分的围手术期预防用药,降低剖宫产术后伤口并发症和产后非计划门诊就诊率。

重点

· 行择期剖宫产的 3 级肥胖患者伤口并发症发生率较高。· 标准剂量阿奇霉素可降低 3 级肥胖患者剖宫产术后伤口感染风险。· 标准剂量阿奇霉素可降低 3 级肥胖患者的再入院率和非计划门诊就诊率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索